Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
3
×
life sciences
national
national blog main
national top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
abbvie
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
multiple myeloma
new york blog main
new york top stories
pulmonx
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
What
ipo
3
×
bio
covid
developing
medicines
roundup
acquisitions
activity
announced
approvals
biogen
blood
broader
cancer
ceo
clamped
collabs
company
daniel
deal
delays
detect
economic
fast
fda
files
firms
gilead
gilead’s
grail
help
including
intended
introduce
investors
isn’t
join
life
lot
month
Language
unset
Current search:
cancer
×
ipo
×
novartis
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More